We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 20 of 598 for:    Recruiting, Not yet recruiting, Available Studies | "Muscular Diseases"

Measurement of the Distribution of Optical Properties in Adult Human Muscle

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00540683
Recruitment Status : Recruiting
First Posted : October 8, 2007
Last Update Posted : February 10, 2017
Sponsor:
Collaborator:
Information provided by (Responsible Party):

Study Description
Brief Summary:
The researcher can use Diffuse Optical spectroscopy technique that uses harmless levels of near-infrared light to probe the concentrations and states of important physiological molecules such as hemoglobin water and lipids in human muscle,.

Condition or disease Intervention/treatment
Muscle Disorder Device: Diffuse Optical Spectroscopy

Detailed Description:

The researcher can monitor muscle physiology, for example during exercise or in response to external factors such as shock by Diffuse Optical spectroscopy technique.

The Diffuse Optical spectroscopy technique can determine significant changes in muscle, muscle structure, muscle tissues metabolism and hemodynamics.


Study Design

Study Type : Observational
Estimated Enrollment : 140 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Measurement of the Distribution of Optical Properties in Adult Human Muscle
Study Start Date : October 2004
Estimated Primary Completion Date : July 2018
Estimated Study Completion Date : July 2018
Groups and Cohorts

Intervention Details:
    Device: Diffuse Optical Spectroscopy
    Muscle properties

Outcome Measures

Primary Outcome Measures :
  1. Healthy Muscle [ Time Frame: upto 4 weeks ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 75 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Study population will be selected from outpatient clinic at University Of California Irvine, and staffs and students.
Criteria

Inclusion Criteria:

  • Male or Female age 18 years and older
  • Diagnosed of Cachexic condition
  • Diagnosed of Cellulite adult female 18 years and older

Exclusion Criteria:

  • Pregnant women
  • Taking light sensitive drugs for use in photodynamic therapy
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00540683


Contacts
Contact: Montana Compton, R.N 949-824-9265 mocomton@uci.edu

Locations
United States, California
Beckman Laser Institute University of California Irvine Recruiting
Irvine, California, United States, 92612
Contact: Montana Compton, R.N    949-824-9265    mocomton@uci.edu   
Principal Investigator: Bruce J Tromberg, Ph.D         
Sub-Investigator: Montana Compton, RN         
Sub-Investigator: Amanda Durkin, BS         
Sub-Investigator: Robert Warren, BS         
Sub-Investigator: Goutham Ganesan, BS         
Sub-Investigator: Thomas O'Sullivan, PhD         
Sub-Investigator: Anais Leproux, Ph.D.         
Sponsors and Collaborators
University of California, Irvine
Beckman Laser Institute University of California Irvine
Investigators
Principal Investigator: Bruce Tromberg, Ph.D Beckman Laser Institute University of California Irvine
More Information

Responsible Party: Beckman Laser Institute and Medical Center, Bruce Tromberg,Ph.D.,Director, Beckman Laser Institute and Medical Clinic and Professor, Departments of Biomedical Engineering and Surgery, University of California, Irvine
ClinicalTrials.gov Identifier: NCT00540683     History of Changes
Other Study ID Numbers: NIH/LAMMP-2004-3626
First Posted: October 8, 2007    Key Record Dates
Last Update Posted: February 10, 2017
Last Verified: February 2017

Additional relevant MeSH terms:
Muscular Diseases
Musculoskeletal Diseases
Neuromuscular Diseases
Nervous System Diseases